SYNCOMF
Invest with MTF
Invest Now
Invest in Syncom Formulation (India) with 2.04X leverage
Performance
- Low
- ₹13
- High
- ₹13
- 52 Week Low
- ₹13
- 52 Week High
- ₹23
- Open Price₹13
- Previous Close₹13
- Volume2,035,228
- 50 DMA₹15.09
- 100 DMA₹15.94
- 200 DMA₹16.73
Investment Returns
- Over 1 Month -11.91%
- Over 3 Month -22.5%
- Over 6 Month -30.22%
- Over 1 Year -27.33%
Smart Investing Starts Here Start SIP with Syncom Formulation (India) for Steady Growth!
Syncom Formulation (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.6
- PEG Ratio
- 0.2
- Market Cap Cr
- 1,237
- P/B Ratio
- 3.3
- Average True Range
- 0.44
- EPS
- 0.67
- Dividend Yield
- 0
- MACD Signal
- -0.4
- RSI
- 25.73
- MFI
- 34.18
Syncom Formulation (India) Financials
Syncom Formulation (India) Technicals
EMA & SMA
Current Price
₹13.16
+
0.03
(0.23%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹14.30
- 50 Day
- ₹15.09
- 100 Day
- ₹15.94
- 200 Day
- ₹16.73
Resistance and Support
13.26
- R3 13.88
- R2 13.72
- R1 13.42
- S1 12.96
- S2 12.80
- S3 12.50
Syncom Formulation (India) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-08-08 | Quarterly Results & A.G.M. | |
| 2025-05-19 | Audited Results | |
| 2025-02-10 | Quarterly Results & Others | To consider other business matters. alia, 1. To consider and allot upto 15,93,47,820 Warrants of Rs. 2.53 convertible into equity shares of Rs. 1/- each at a premium of Rs. 1.53 per share for every warrant of the company. |
| 2024-11-11 | Quarterly Results |
Syncom Formulation (India) F&O
About Syncom Formulation (India)
- NSE Symbol
- SYNCOMF
- BSE Symbol
- 524470
- Managing Director
- Mr. Vijay Shankarlal Bankda
- ISIN
- INE312C01025
Similar Stocks to Syncom Formulation (India)
Syncom Formulation (India) FAQs
Syncom Formulation (India) share price is ₹13 As on 12 January, 2026 | 16:29
The Market Cap of Syncom Formulation (India) is ₹1237 Cr As on 12 January, 2026 | 16:29
The P/E ratio of Syncom Formulation (India) is 19.6 As on 12 January, 2026 | 16:29
The PB ratio of Syncom Formulation (India) is 3.3 As on 12 January, 2026 | 16:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.